Amgen, DuBiotech explore expansion plans

Dubai Biotechnology and Research Park (DuBiotech), a major life sciences hub in the Middle East and a member of Tecom Investments, yesterday announced that it discussed expansion plans with Amgen International during a meeting of senior management.

Amgen is the world's largest biotechnology company with an estimated market capitalisation of $65 billion. It was one of the first biotech companies to establish operations in the Middle East.

Founded in 2006, Amgen's local organisation has since launched activities in several countries in the Middle East, as well as Turkey and South Africa. The headquarters for Amgen's MEAT (Middle East, Africa and Turkey) operations is located at the Dubai Biotechnology and Research Park.